Review of Controlled Psychotherapy Treatment Trials for Binge Eating Disorder

2008 ◽  
Vol 102 (2) ◽  
pp. 339-368 ◽  
Author(s):  
Valerie L. Krysanski ◽  
F. Richard Ferraro
Keyword(s):  
Eating Disorder ◽  
Binge Eating ◽  
Binge Eating Disorder ◽  
Treatment Options ◽  
Current Debate ◽  
Eating Patterns ◽  
Controlled Clinical Trials ◽  
Randomized Controlled Clinical Trials ◽  
Randomized Controlled ◽  
A Current

This paper reviews investigations of psychotherapy outcome studies for binge eating disorder, which has recently been intensively studied as several researchers have undertaken the task of delineating which treatment options are the most effective. Several randomized, controlled clinical trials have provided important findings. A current debate concerns what the initial course of treatment should be, reducing binge eating patterns or reducing weight. Several limitations to this literature are mentioned, including the dearth of studies investigating treatment for men and boys with binge eating disorder.

scholarly journals EEG Neurofeedback in the Treatment of Adults with Binge-Eating Disorder: a Randomized Controlled Pilot Study

2021 ◽  
Author(s):  
Marie Blume ◽  
Ricarda Schmidt ◽  
Jennifer Schmidt ◽  
Alexandra Martin ◽  
Anja Hilbert
Keyword(s):  
Eating Disorder ◽  
Pilot Study ◽  
Binge Eating ◽  
Binge Eating Disorder ◽  
Brain Activity ◽  
Treatment Options ◽  
Beta Activity ◽  
Randomized Controlled ◽  
Eeg Neurofeedback

AbstractSpecific alterations in electroencephalography (EEG)-based brain activity have recently been linked to binge-eating disorder (BED), generating interest in treatment options targeting these neuronal processes. This randomized-controlled pilot study examined the effectiveness and feasibility of two EEG neurofeedback paradigms in the reduction of binge eating, eating disorder and general psychopathology, executive functioning, and EEG activity. Adults with BED and overweight (N = 39) were randomly assigned to either a food-specific EEG neurofeedback paradigm, aiming at reducing fronto-central beta activity and enhancing theta activity after viewing highly palatable food pictures, or a general EEG neurofeedback paradigm training the regulation of slow cortical potentials. In both conditions, the study design included a waiting period of 6 weeks, followed by 6 weeks EEG neurofeedback (10 sessions à 30 min) and a 3-month follow-up period. Both EEG neurofeedback paradigms significantly reduced objective binge-eating episodes, global eating disorder psychopathology, and food craving. Approximately one third of participants achieved abstinence from objective binge-eating episodes after treatment without any differences between treatments. These results were stable at 3-month follow-up. Among six measured executive functions, only decision making improved at posttreatment in both paradigms, and cognitive flexibility was significantly improved after food-specific neurofeedback only. Both EEG neurofeedback paradigms were equally successful in reducing relative beta and enhancing relative theta power over fronto-central regions. The results highlight EEG neurofeedback as a promising treatment option for individuals with BED. Future studies in larger samples are needed to determine efficacy and treatment mechanisms.

scholarly journals Topiramate: use in binge eating disorder?

2012 ◽  
pp. 282-287
Author(s):  
Mauro Gentile ◽  
Giovanni Scanelli
Keyword(s):  
Eating Disorder ◽  
Side Effects ◽  
Binge Eating ◽  
Binge Eating Disorder ◽  
Search Strategy ◽  
Current Knowledge ◽  
Significant Weight Loss ◽  
Good Tool ◽  
Randomized Controlled ◽  
Treatment Of Diabetes

Introduction: Topiramate was serendipitously synthesized in 1979 during research aimed at developing a fructose-1,6-diphosphatase inhibitor that might be used in the treatment of diabetes mellitus. Some investigators have suggested it might be used in the treatment of binge eating disorder (BED). The aim of this review was to evaluate current knowledge and opinions on this topic. Materials and methods: We conducted a search of five electronic databases (PubMed, Embase, Nice, Cochrane, Cinahl) using the search strategy ‘‘topiramate’’ AND ‘‘binge’’, ‘‘binge eating disorder.’’ No time limits were applied, and only reports of randomized controlled trials were included in our analysis. Results: In clinical studies, topiramate use has been associated with significant weight loss mediated by reductions in the frequency of bingeing episodes. The most common side effects of the drug are paresthesias, but nephrolithiasis, oligohydrosis, and dizziness have also been described. Conclusions: Available data are limited, but the literature we reviewed suggests that topiramate can be useful in the medical treatment of BED, reducing both body weight and binge episodes. Side effects are not negligible. Before topiramate can be regarded as a good tool for the treatment of BED, further data must be obtained from longer, methodologically correct studies of larger populations.

Adapted motivational interviewing for women with binge eating disorder: A randomized controlled trial.

2008 ◽  
Vol 22 (3) ◽  
pp. 417-425 ◽  
Author(s):  
Stephanie E. Cassin ◽  
Kristin M. von Ranson ◽  
Kenneth Heng ◽  
Joti Brar ◽  
Amy E. Wojtowicz
Keyword(s):  
Randomized Controlled Trial ◽  
Eating Disorder ◽  
Binge Eating ◽  
Motivational Interviewing ◽  
Binge Eating Disorder ◽  
Controlled Trial ◽  
Randomized Controlled

Treatments for Eating Disorders

2015 ◽  
Author(s):  
Kathleen M. Pike ◽  
Loren M. Gianini ◽  
Katharine L. Loeb ◽  
Daniel Le Grange
Keyword(s):  
Eating Disorders ◽  
Weight Loss ◽  
Eating Disorder ◽  
Bulimia Nervosa ◽  
Binge Eating ◽  
Binge Eating Disorder ◽  
Behavioral Therapy ◽  
Treatment Options ◽  
Evidence Based Treatments ◽  
Substantial Progress

Substantial progress in advancing evidence-based treatments for eating disorders has been made. Many well-designed studies provide cumulative support for cognitive-behavioral therapy (CBT) as the treatment of choice for bulimia nervosa. Interpersonal psychotherapy (IPT) and pharmacotherapy are considered appropriate alternative treatments for bulimia nervosa. While CBT, IPT and pharmacotherapy often produce significant reductions in binge eating and compensatory behaviors, these treatment options need to be improved to help more individuals achieve full and lasting recovery. In the treatment of binge eating disorder, CBT and IPT have been shown to be the most efficacious in reducing symptoms and improving psychological outcomes. Weight loss is often an additional goal of those entering treatment for binge eating disorder; however, existing treatments have generally been unsuccessful in producing significant maintainable weight loss. Initial studies suggest that CBT may be associated with improved outcome both in the acute and maintenance phases of treatment for anorexia nervosa.

Sign in / Sign up

Export Citation Format

Share Document